A sample report by Clearstate

Unparalleled depth and actionable intelligence about South Korea’s in-vitro diagnostics market

The IVD market in South Korea reached US$1.0 billion in 2022. Over the next five years, growth is expected to increase by 2.2% CAGR with an ageing population and increased healthcare expenditure.

SARS-COV-2 rapid antigen tests and PCR tests volume will continue to decline in 2023 and 2024, but what will the post-pandemic recovery for other IVD test segments look like?

This sample report offers a glance at the granular insights and in-depth analysis awaiting you in the full Segment Trend Report about South Korea’s IVD market.

Download now

Download sample report

Simply fill in the form below to access this free report.